A Turkish Gynecologic Oncology Group study of fertility‐sparing treatment for early‐stage endometrial cancer
Authors:
- Polat DursunPDPolat Dursun
- Serkan ErkanliSESerkan Erkanli
- Ahmet Bariş GüzelAGAhmet Bariş Güzel
- Murat GultekinMGMurat Gultekin
- Nefise Cagla TarhanNTNefise Cagla Tarhan
- Ozden AltundagOAOzden Altundag
- Fuat DemirkiranFDFuat Demirkiran
- Tugan BeşeTBTugan Beşe
- Yusuf YildirimYYYusuf Yildirim
- Gurkan BozdagGBGurkan Bozdag
- Hakan YaraliHYHakan Yarali
- Tayyup SimsekTSTayyup Simsek
- 24 August 2012
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 119 (3) , 270-273
Abstract
Objective: To analyze the results of fertility‐sparing treatment of early‐stage endometrial cancer (EC) in patients treated at Turkish gynecologic oncology centers, and to present a review of the literature.Methods: Thirteen healthcare centers in Turkey were contacted to determine if they were eligible to participate in the study. Centers that were eligible and agreed to participate were sent a database form to record the demographic characteristics, clinicopathologic findings, and follow‐up results for their EC patients.Results: Eleven Turkish healthcare centers provided data on 43 EC patients. Mean duration of treatment was 5 months and mean follow‐up was 49 months. In total, 35 (81.4%) patients were tumor free following primary progesterone therapy. Mean time from the end of progesterone therapy to pregnancy was 10.6 ± 4.3 months (range, 3–18 months). Two patients had tumor recurrence during follow‐up. The pregnancy rate among the 31 women who actively sought pregnancy was 41.9% (n = 13).Conclusion: Conservative management of early‐stage EC in women of reproductive age using oral progestins was effective and did not compromise oncological outcome. Pregnancy in the study patients was achieved spontaneously and artificially.Keywords
This publication has 22 references indexed in Scilit:
- Conservative treatment of early endometrial cancer: Preliminary results of a pilot studyGynecologic Oncology, 2011
- Prolonged Conservative Treatment of Endometrial Cancer PatientsInternational Journal of Gynecological Cancer, 2011
- Fertility-Sparing Therapy in Young Women With Endometrial CancerInternational Journal of Gynecological Cancer, 2010
- Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young WomenJournal of Clinical Oncology, 2007
- Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature reviewGynecologic Oncology, 2004
- Endometrial Carcinoma Remaining after Term Pregnancy Following Conservative Treatment with Medroxyprogesterone AcetateGynecologic Oncology, 2000
- Does hysteroscopy facilitate tumor cell dissemination?Cancer, 2000
- Progestin alone as primary treatment of endometrial carcinoma in premenopausal womenCancer, 1997
- The treatment of advanced endometrial cancer with hydroxyprogesterone caproateGynecologic Oncology, 1974
- Progestational Agents in the Treatment of Carcinoma of the EndometriumNew England Journal of Medicine, 1961